Pneumocandin B0(L-688786), a key intermediate in the synthesis of the antifungal agent, Cancidas, has led to the identification of several materials with potential for improved performance.
Researchers modified pneumocandin B0 with sulfonium groups to create antifungals that evade resistance in Cryptococcus neoformans, addressing the limited treatment options for fungal infections.
ChemBrief